Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (ISRCTN12805381) titled 'Testing whether patients and researchers presenting side-by-side improves communication of scleroderma research to patients' on Aug. 4.
Study Type: Interventional
Study Design:
Mixed-method involving a two-arm parallel-group randomized controlled trial (RCT) embedded in a 90-minute virtual research event and interview study (Quality of life)
Primary Sponsor: Jewish General Hospital
Condition:
Patient and researcher co-presentation of research results compared to researcher-alone presentation among people with systemic sclerosis.
Other
Intervention:
This will be a mixed-method study with (1) a two-arm paral...